R
Rongye Shi
Researcher at National Institutes of Health
Publications - 10
Citations - 424
Rongye Shi is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 5, co-authored 10 publications receiving 221 citations.
Papers
More filters
Journal ArticleDOI
Effects of Systemically Administered Hydrocortisone on the Human Immunome.
Matthew J. Olnes,Matthew J. Olnes,Yuri Kotliarov,Angelique Biancotto,Foo Cheung,Jinguo Chen,Rongye Shi,Huizhi Zhou,Ena Wang,Ena Wang,John S. Tsang,Robert B. Nussenblatt +11 more
TL;DR: This study is the first to systematically characterize the effects of corticosteroids on the human immunome, and it is demonstrated that HC exerts differential effects on B and T lymphocytes and natural killer cells in humans.
Journal ArticleDOI
PBMC fixation and processing for Chromium single-cell RNA sequencing.
TL;DR: It is expected that the methanol-based cell fixation procedure presented here will allow better and more effective batching schemes for a complex single cell experimental design with primary cells or tissues.
Journal ArticleDOI
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
Sarfaraz Hasni,Sarthak Gupta,Michael Davis,Elaine Poncio,Yenealem Temesgen-Oyelakin,Philip M. Carlucci,Xinghao Wang,Mohammad Naqi,Martin P. Playford,Rishi R. Goel,Xiaobai Li,Ann Biehl,Isabel Ochoa-Navas,Zerai Manna,Yinghui Shi,Donald E Thomas,Jinguo Chen,Angelique Biancotto,Richard Apps,Foo Cheung,Yuri Kotliarov,Ashley Babyak,Huizhi Zhou,Rongye Shi,Katie Stagliano,Wanxia Li Tsai,Laura Vian,Nathalia R Gazaniga,Valentina Giudice,Shajia Lu,Stephen R. Brooks,Meggan Mackay,Peter K. Gregersen,Nehal N. Mehta,Alan T. Remaley,Betty Diamond,John J. O'Shea,Massimo Gadina,Mariana J. Kaplan +38 more
TL;DR: Tofacitinib improves high-density lipoprotein cholesterol levels (p = 0.0008, CI 95%: 1.58, 5.33); lecithin: cholesterol acyltransferase concentration (p à 0.08, CI à − 0.01, 0.24), improvements in arterial stiffness and endothelium-dependent vasorelaxation and decrease in type I IFN gene signature, low-density granulocytes and circulating NETs as discussed by the authors.
Journal ArticleDOI
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
Meghali Goswami,Gabrielle T. Prince,Angelique Biancotto,Susan Moir,Lela Kardava,Brian H. Santich,Foo Cheung,Yuri Kotliarov,Jinguo Chen,Rongye Shi,Huizhi Zhou,Hana Golding,Jody Manischewitz,Lisa King,Lauren M. Kunz,Kimberly A. Noonan,Ivan Borrello,B. Douglas Smith,Christopher S. Hourigan +18 more
TL;DR: While some aspects of cellular immunity recover quickly, humoral immunity is incompletely reconstituted in the year following intensive cytotoxic chemotherapy for AML, suggesting the poor response to vaccination often seen in AML patients after chemotherapy.
Posted ContentDOI
PBMC Fixation and Processing for Chromium Single-Cell RNA Sequencing
TL;DR: It is expected that the methanol-based cell fixation procedure presented here will allow better and more effective batching schemes for a complex single cell experimental design with primary cells or tissues.